FULC Max Pain
The max pain for Fulcrum Therapeutics Inc (FULC) options expiring Mar 19, 2027 (122 DTE) is $4.00.
FULC Max Pain by Expiry
The Max Pain for all expiration dates of FULC.
| Expiration | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Nov 20, 2026 3 DTE monthly | 4.00 | 0.22 (5.82%) |
| Dec 18, 2026 31 DTE monthly | 4.00 | 0.22 (5.82%) |
| Jan 15, 2027 59 DTE monthly | 4.00 | 0.22 (5.82%) |
| Mar 19, 2027 122 DTE monthly | 4.00 | 0.22 (5.82%) |
| Jun 17, 2027 212 DTE weekly | 3.00 | -0.78 (-20.63%) |
FULC Max Pain FAQ
What is max pain?
Max pain is the price where the total value of all open calls and puts would be lowest at expiration, so option buyers as a group would lose the most. Some traders watch it as a level the stock may drift toward near expiration, because option sellers, often market makers, hedge their positions in ways that can pull the price toward heavily traded strikes. It is a theory, not a guarantee.
What is FULC max pain this week?
As of the Nov 17, 2026 close, max pain for Fulcrum Therapeutics options expiring Mar 19, 2027 is $4.00. The chart above shows the exact max pain for each expiration date.
Does FULC trade above or below its max pain?
Fulcrum Therapeutics closed above its near-term max pain on 0 of the last 20 trading days. On Nov 17, 2026 it closed at $3.75, 6.3% below max pain of $4.00.
How has FULC max pain changed recently?
Over the last 20 trading days, near-term max pain for Fulcrum Therapeutics ranged from $4.00 to $4.33. It went from $4.33 on Oct 21, 2026 to $4.00 on Nov 17, 2026. See the FULC max pain history for a longer view.
What is Fulcrum Therapeutics Inc?
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases.